There were 30 notable investor filings today. Eastman Chemical Company (NYSE:EMN) is the largest company of interest.
JP Morgan Chase & Co has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,795,905 shares of Eastman Chemical Company (NYSE:EMN). This represents 4.7 percent ownership of Eastman Chemical Company. Previously, JP Morgan Chase & Co had reported owning 9,460,072 shares, indicating a decrease of -28.16 percent. Eastman Chemical Company has declared a standard industrial code (sic) of 2821 which is the “Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers” industry.
When a person or group of persons acquires beneficial ownership of more than 5% of a company’s equity securities, they are required to file a Schedule 13D or 13G with the SEC. If these groups intend to influence management into changing the business strategy, they are considered “activist” investors. There is considerable academic research that suggest activist investors contribute to excess returns in equities in the subsequent twelve months after the event.
Investors that acquire 10% or more of a company’s shares, or that gain a board seat, are considered insiders by the SEC and are subject to stricter insider trading filing requirements.
New Activist Investor Filings
Investors that acquire more than 5% of the shares of a company and intend to influence management are considered activist investors and must file a 13D.
WSI Industries, Inc. (WSCI) – Digital Power Corp has filed a new SC 13D, reporting a 7.76% ownership stake in WSI Industries.
Houston Wire & Cable Co. (HWCC) – Nierenberg Investment Management Company, Inc. has filed a new SC 13D, reporting a 9.00% ownership stake in Houston Wire & Cable Co.. This is an increase of 8.43% from their previous filing.
Beacon Roofing Supply, Inc. (BECN) – Cd&r Boulder Holdings, L.p. has filed a new SC 13D, reporting a 12.50% ownership stake in Beacon Roofing Supply.
Amended Activist Investor Filings
SeaSpine Holdings Corporation (SPNE) – Essig Stuart has filed an amended Schedule 13D/A, reporting a 4.40% ownership stake in SeaSpine Holdings. This is a decrease of 25.42% from their previous filing.
CVR Partners, LP (UAN) – Blackstone Holdings I L.P. has filed an amended Schedule 13D/A, reporting a 6.90% ownership stake in CVR Partners. This is a decrease of 18.82% from their previous filing.
Town Sports International Holdings, Inc. (CLUB) – PW Partners Atlas Fund III, LP has filed an amended Schedule 13D/A, reporting a 13.90% ownership stake in Town Sports International Holdings. This is a decrease of 11.46% from their previous filing.
Concurrent Computer Corp. (CCUR) – Vecima Networks Inc. has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Concurrent Computer. This is a decrease of 100.00% from their previous filing.
Safety, Income & Growth Inc. (SAFE) – Istar Inc. has filed an amended Schedule 13D/A, reporting a 37.70% ownership stake in Safety, Income & Growth. This is an increase of 2.72% from their previous filing.
Amended Passive Investor Filings
Viking Therapeutics, Inc. (VKTX) – Evans Daron has filed an amended Schedule 13D/A, reporting an updated ownership stake in Viking Therapeutics.
Alkermes plc (ALKS) – Primecap Management Co/ca/ has filed an amended Schedule 13D/A, reporting a 14.26% ownership stake in Alkermes. This is an increase of 25.64% from their previous filing.
Axcelis Technologies, Inc. (ACLS) – Primecap Management Co/ca/ has filed an amended Schedule 13D/A, reporting a 9.67% ownership stake in Axcelis Technologies. This is a decrease of 18.33% from their previous filing.
Flex Pharma, Inc. (FLKS) – Primecap Management Co/ca/ has filed an amended Schedule 13D/A, reporting a 10.05% ownership stake in Flex Pharma. This is an increase of 66.67% from their previous filing.
OncoSec Medical Incorporated (ONCS) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 3.23% ownership stake in OncoSec Medical. This is a decrease of 45.71% from their previous filing.
Cytori Therapeutics, Inc. (CYTX) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 2.93% ownership stake in Cytori Therapeutics. This is a decrease of 63.65% from their previous filing.
Superconductor Technologies, Inc. (SCON) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 4.99% ownership stake in Superconductor Technologies. This is a decrease of 50.05% from their previous filing.
RiceBran Technologies (RIBT) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 4.99% ownership stake in RiceBran Technologies. This is a decrease of 38.55% from their previous filing.
Cellectar Biosciences, Inc. (CLRB) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 0.80% ownership stake in Cellectar Biosciences. This is a decrease of 88.37% from their previous filing.
Tenax Therapeutics, Inc. (TENX) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 0.00% ownership stake in Tenax Therapeutics. This is a decrease of 100.00% from their previous filing.
Cleveland BioLabs, Inc. (CBLI) – Sabby Management, LLC has filed an amended Schedule 13D/A, reporting a 1.33% ownership stake in Cleveland BioLabs. This is a decrease of 83.38% from their previous filing.
La Quinta Holdings Inc. (LQ) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.60% ownership stake in La Quinta Holdings. This is a decrease of 8.00% from their previous filing.
Wayfair, Inc. (W) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.50% ownership stake in Wayfair. This is a decrease of 22.41% from their previous filing.
HFF, Inc. (HF) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.80% ownership stake in HFF. This is a decrease of 25.00% from their previous filing.
RBC Bearings, Inc. (ROLL) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.80% ownership stake in RBC Bearings. This is a decrease of 11.11% from their previous filing.
TreeHouse Foods, Inc. (THS) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 1.90% ownership stake in TreeHouse Foods. This is a decrease of 71.64% from their previous filing.
Cross Country Healthcare, Inc. (CCRN) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.10% ownership stake in Cross Country Healthcare. This is a decrease of 51.19% from their previous filing.
Exelixis, Inc. (EXEL) – Meditor Group Ltd has filed an amended Schedule 13D/A, reporting an updated ownership stake in Exelixis.
Bill Barrett Corp. (BBG) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.00% ownership stake in Bill Barrett. This is a decrease of 37.50% from their previous filing.
Eastman Chemical Company (EMN) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.70% ownership stake in Eastman Chemical. This is a decrease of 26.56% from their previous filing.
General Cable Corp. (BGC) – JP Morgan Chase & Co has filed an amended Schedule 13D/A, reporting a 4.00% ownership stake in General Cable. This is a decrease of 25.93% from their previous filing.
Cytori Therapeutics, Inc. (CYTX) – Azaya Therapeutics Inc has filed an amended Schedule 13D/A, reporting an updated ownership stake in Cytori Therapeutics.
Fintel provides free investor tools for data driven investors. See all new activist filings at Fintel.io/activists and new 13F filings at Fintel.io/latest-13f-filings.
